CrossrefInfokarte
Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating MPS IIIB: Toxicology, Bio-distribution and Immunological Assessments in Primates
Human Gene Therapy Clinical Development · 2014
DOI: 10.1089/hum.2013.208 ↗Abstract
Kein Abstract verfügbar.
EUVIMED